HemOnc Today New York

The latest news from the annual meeting, including video perspective from faculty members and attendees.

Meeting News CoverageVideo

VIDEO: Clinical differences can help identify adnexal primary vs. metastatic carcinoma

April 4, 2016
NEW YORK — Jane L. Messina, MD, an anatomic pathologist of the Melanoma Research Center of Excellence at Moffitt Cancer Center, discussed the…
Meeting News CoverageVideo

VIDEO: Targeted therapy ‘not enough’ for long-term melanoma treatment

April 1, 2016
NEW YORK — Christian Blank, MD, PhD, staff member in medical oncology and group leader of the division of immunology at Netherlands Cancer…
Meeting News CoverageVideo

VIDEO: Speaker outlines challenges of biomarker development

March 31, 2016
NEW YORK — Janice M. Mehnert, MD, director of developmental therapeutics for melanoma and soft tissue oncology at Rutgers Cancer Institute of…
Meeting News CoverageVideo

VIDEO: Rational strategy necessary for clinical follow-up in melanoma

March 30, 2016
NEW YORK — Merrick I. Ross, MD, professor in the department of surgery at The University of Texas MD Anderson Cancer Center, offered…
Meeting News CoverageVideo

VIDEO: Consumer dermoscopy ‘only as good as its user’

March 29, 2016
NEW YORK —Suraj S. Venna, MD, medical director at Inova Melanoma and Skin Cancer Center, reviewed data on the efficacy of self-diagnosis of…
Meeting News Coverage

Updates in staging, management may benefit future of Merkel cell carcinoma treatment

March 27, 2016
NEW YORK — Updates to the staging system and management guidelines for Merkel cell carcinoma may help clinicians in the appropriate treatment…
Meeting News CoverageVideo

VIDEO: Highlights from the 2016 HemOnc Today Melanoma and Cutaneous Malignancies meeting

March 23, 2016
NEW YORK — Sanjiv S. Agarwala, MD, professor of medicine at Temple University School of Medicine, chief of hematology and oncology at St…
Meeting News Coverage

‘Explosion of genomic data’ should improve treatment of cutaneous T-cell lymphoma

March 22, 2016
NEW YORK — An increasing knowledge of the genomics underlying cutaneous T-cell lymphoma may soon lead to targeted therapies for this disease…
Meeting News CoverageVideo

VIDEO: Speaker provides updates on BRAF/MEK combination therapies

March 21, 2016
NEW YORK — Jason J. Luke, MD, FACP, assistant professor of Medicine at The University of Chicago Medicine, discussed the current status of the…
Meeting News Coverage

Early, late initiation of ipilimumab induce similar response rates in unresectable or metastatic melanoma

March 21, 2016
NEW YORK — The timing of ipilimumab initiation in the course of treatment for unresectable or metastatic melanoma had no significant effect on…